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494Inhibition of RNA Polymerase
by Streptolydigin:
No Cycling Allowed
Bacterial RNA polymerase is a common target for
many antibiotics. In two recent papers in Cell and Mo-
lecular Cell, Tuske et al. (2005) and Temiakov et al.
(2005) describe a structural basis for inhibition of
bacterial RNA polymerase by the antibiotic strepto-
lydigin. Streptolydigin may prevent distortion of a
“bridge”  helix postulated to occur during the nucle-
otide addition cycle of RNA polymerase or may block
a small movement of the bridge helix that helps load
nucleotide triphosphates into the active site.
An essential part of transcription is the addition of nu-
cleotides by RNA polymerase (RNAP) to the nascent
mRNA transcript. The antibiotic streptolydigin inhibits
bacterial, but not eukaryotic, RNAPs. By examining the
structure of streptolydigin bound to RNAP, Tuske et al.
(2005) and Temiakov et al. (2005) address the mecha-
nism of inhibition of RNAP by this antibiotic. The results
from these studies provide insights not only into the
action of streptolydigin but also into the nucleotide ad-
dition mechanism of RNAP.
The nucleotide addition cycle of RNAP (Figure 1A)
consists minimally of (1) translocation of the RNA 3#
nucleotide from the insertion site (also variously re-
ferred to as i+1, substrate site or A site) to the product
site in RNAP (i site); (2) nucleotide triphosphate (NTP)
binding; (3) catalysis of nucleotide monophosphate ad-
dition; and (4) release of pyrophosphate (PPi). Recent
studies suggest that NTPs reach the insertion site after
first binding to a nearby entry site and then moving to
a pre-insertion site (Figure 1A; Sosunov et al., 2003;
Westover et al., 2004; Kettenberger et al., 2004). Al-
ternation of the bridge helix (a 37 aa α helix that spans
RNAP’s two large subunits just downstream of the
active site) between a straight (i.e, continuous) confor-
mation (previously observed in all S. cerevisiae RNAPII
crystals; Figure 1B, left) and a distorted conformation
(previously observed in all bacterial RNAP crystals; Fig-
ure 1B, right) is proposed to assist translocation (Gnatt
et al., 2001, Bar-Nahum et al., 2005; and references
therein).
Although it was known that streptolydigin blocks ini-
tiation, elongation, and pyrophosphorolysis by RNAP
(see references in Tuske et al., 2005), the precise mech-
anism of inhibition was unclear. The new crystal struc-
tures of Thermus thermophilus RNAP bound to strepto-
lydigin described in these two papers define the
streptolydigin binding site and propose a mechanism
of inhibition for this antibiotic. Both groups found the
same binding site adjacent to the bridge helix and dis-
tinct from the NTP binding sites. Streptolydigin con-
tacts four distinct structural elements in RNAP: βD
loops I and II, previously proposed to participate in
conformational closing of RNAP’s active site (Korzheva
et al., 2000; called STL1 and STL2 in Temiakov et al.,
2005); the bridge helix; and a highly mobile loop in the
RNAP secondary channel called the trigger loop (see
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sigure 1 in Temiakov et al., 2005 and Figure 3B in Tuske
t al., 2005). The binding of this antibiotic shifts the
onformation of all four structural elements (see Figure
in Temiakov et al., 2005). In addition to the cocrystal,
uske et al. (2005) report a comprehensive map of
treptolydigin resistance substitutions involving all four
lements, which includes previously reported resis-
ance substitutions (see citations in Tuske et al., 2005)
nd validates the biological relevance of the crystallo-
raphically detected binding site. Some resistance
ubstitutions in residues of βD loop II, the bridge helix,
nd the trigger loop do not contact streptolydigin in
he crystal structures (Tuske et al., 2005). The apparent
llosteric effects of these substitutions support the
unctional importance of conformational changes in
hese elements, notably in the bridge helix, for nucleo-
ide addition.
Tuske et al. (2005) focus on the effects of streptolydi-
in on the bridge helix conformation and its much-dis-
ussed, possible relationship to RNAP translocation
tates. The streptolydigin-RNAP cocrystal structures
apture the bridge helix of bacterial RNAP in a straight
onformation for the first time, thus establishing that a
iven RNAP can form either a straight or distorted
ridge helix. They also show a streptolydigin-induced
hift in the translocation equilibrium toward the post-
ranslocated state using exonuclease III (Exo III) foot-
rinting of halted transcription elongation complexes (a
echnique that determines, at the nucleotide level, the
xact position of a DNA molecule in a transcription
omplex). These data suggest a correlation between
ridge helix conformation and translocation, which
ould be consistent both with the earlier speculation
f bridge-helix-driven translocation and with the sug-
estion that streptolydigin alters the translocation equi-
ibrium (McClure, 1980). However, significant caveats
pply to this interpretation. First, streptolydigin favors
he straight helix and the posttranslocated state, oppo-
ite to the previous notion that the bridge-helix distor-
ion would favor the posttranslocated state. Second,
treptolydigin inhibits even a single round of NTP addi-
ion in a halted transcription elongation complex (Temi-
kov et al., 2005), which is not easily explained simply
y trapping the elongation complex in the posttranslo-
ated conformation. Finally, although demonstration
hat the bridge helix can be straight in bacterial RNAP
s important, the distorted conformation (Figure 1B,
ight) is yet to be detected in either pre- or posttranslo-
ated elongation complex structures (Gnatt et al., 2001;
estover et al., 2004). Tuske et al. thus limit their pro-
osal to suggesting that streptolydigin affects confor-
ational cycling of RNAP, most likely involving the
ridge-helix distortion at an unspecified step in the nu-
leotide addition cycle other than NTP binding.
Temiakov et al. propose a more specific model for
treptolydigin action, which involves only a minor
ovement of the bridge helix to assist a specific step
n the nucleotide addition cycle. The authors find that
treptolydigin does not affect apparent Km for NTP, in
greement with Tuske et al. (2005), but acts at a step
efore nucleotide monophosphate incorporation and,
mportantly, does not affect translocation, also assayed
y Exo III footprinting. These results fit nicely with
treptolydigin inhibition of NTP transfer from the pre-
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495Figure 1. Structural Models for Streptolydigin
Inhibition of RNA Polymerase
(A) The nucleotide addition cycle consists of
four major steps: translocation, NTP binding,
catalysis, and PPi release. NTP binding can
be further divided into three substeps: initial
NTP entry at the entry site (ES), NTP loading
from ES to the pre-insertion site (PS), and
NTP insertion from PS to the insertion site
(IS; same as i+1 site).
(B) Streptolydigin (stl) inhibits RNAP by
blocking conformational cycling of the
bridge helix (Tuske et al., 2005). Bridge helix,
cyan; streptolydigin, orange; RNA, red; ES
NTP, magenta; PS NTP, blue; IS NTP, green;
active site Mg2+, yellow; i and i+1 sites, light
blue dotted circles. For clarity, A second
Mg2+, which is recruited to the active site
with NTP, and βD loops I and II as well as the
trigger loop, which are important for strepto-
lydigin binding, nucleotide addition, and the
mechanism of streptolydigin action, are not
depicted (see Figure 3B in Tuske et al., 2005
and Figure 1 in Temiakov et al., 2005).
(C) Streptolydigin inhibits RNAP by blocking
NTP insertion from PS to IS (Temiakov et al.,
2005). Structural representations were pre-
pared using PyMOL (DeLano Scientific LLC;
San Carlos, California).insertion site to the insertion site. Unlike previous bac-
terial RNAP structures, Temiakov et al. observe a
straight bridge helix even in the absence of streptolydi-
gin (despite identical experimental conditions). How-
ever, the position of the bridge helix is shifted away
from the active site w2 Å by binding of streptolydigin,
leading the authors to propose that slight movement of
the bridge helix toward the active site could be needed
for NTP transfer from the pre-insertion site to the inser-
tion site and could be blocked by streptolydigin (Figure
1C, right).
Temiakov et al. (2005) combine the various observa-
tions to propose a detailed model that offers the most
comprehensive view to date of the complex trafficking
in RNAP’s active site. In this model, NTPs first ap-
proach the active site by binding in the entry site at the
end of the secondary channel. The authors suggest
that positioning of the entry site NTP triphosphate and
its chelated Mg2+ ion could displace the pretranslo-
cated RNA 3# nucleotide from the insertion site, if trans-
location has not already occurred. This elegant idea
contrasts with alternative proposals for NTP-assistedtranslocation (Gong et al., 2005). In the Temiakov et al.
model, complementary NTPs can then rotate into the
partially overlapping pre-insertion site where they initi-
ate pairing with the template base and then move from
the pre-insertion site to the insertion site in a concerted
structural rearrangement of the nucleic acid and protein
components of the RNAP active site, closing the active
site as observed in T7 RNAP and DNA polymerases.
This movement (NTP insertion) is the step proposed to
be inhibited by streptolydigin.
Aside from what arguably are relatively minor differ-
ences in effects of streptolydigin on Exo III detection of
translocation state (which may be attributed to the use
of different, evolutionarily distant RNAPs) and the mag-
nitude of bridge-helix movements, Tuske et al. (2005)
and Temiakov et al. (2005) present a largely concordant
picture of streptolydigin binding and action, with the
latter group offering a more detailed proposal for the
step at which this antibiotic acts. The next obvious step
would be to test the proposed inhibition mechanisms
directly by crystallizing a bacterial elongation complex
with bound NTP and streptolydigin. The Temiakov et al.
Cell
496model predicts that streptolydigin should trap NTP in
the pre-insertion site in such an elongation complex
structure. Additionally, this cocrystal would be of great
interest because it might reveal a specific role for the
trigger loop in nucleotide binding or insertion. Since it is
often disordered in RNAP crystal structures, the highly
flexible trigger loop has received less attention as a key
player in the nucleotide addition cycle. However, the
structural element most affected by streptolydigin is
this highly conserved loop (its position shifts by at least
11 Å upon streptolydigin binding), whose position in
apo-RNAP clashes extensively with bound streptolydi-
gin. Interestingly, Temiakov et al. report that deletion of
the trigger loop inhibits nucleotide addition more than
10,000-fold, but that the residual activity is actually
stimulated by streptolydigin binding. One wonders if
this hints at a direct role of the trigger loop in nucleotide
addition and in the mechanism of streptolydigin inhibi-
tion that remains underappreciated owing to its elusive
location in many RNAP structures.
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